Explore bluebird bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLUE. Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $ ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the shares after the company announced that it has entered ...

Bluebird Bio (BLUE) announced that it has entered into a definitive agreement to be acquired by funds managed by Carlyle (CG) and SK Capital Partners. David Meek, former CEO of Mirati Therapeutics ...